317 related articles for article (PubMed ID: 24943063)
1. Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin.
Plajer SM; Chin PK; Vella-Brincat JW; Buffery PJ; Begg EJ
Ther Drug Monit; 2015 Feb; 37(1):98-103. PubMed ID: 24943063
[TBL] [Abstract][Full Text] [Related]
2. Once-daily gentamicin dosing in children with febrile neutropenia resulting from antineoplastic therapy.
Inparajah M; Wong C; Sibbald C; Boodhan S; Atenafu EG; Naqvi A; Dupuis LL
Pharmacotherapy; 2010 Jan; 30(1):43-51. PubMed ID: 20030472
[TBL] [Abstract][Full Text] [Related]
3. Eight years' experience of an extended-interval dosing protocol for gentamicin in neonates.
Begg EJ; Vella-Brincat JW; Robertshawe B; McMurtrie MJ; Kirkpatrick CM; Darlow B
J Antimicrob Chemother; 2009 May; 63(5):1043-9. PubMed ID: 19299469
[TBL] [Abstract][Full Text] [Related]
4. Dosing of gentamicin in patients with end-stage renal disease receiving hemodialysis.
Teigen MM; Duffull S; Dang L; Johnson DW
J Clin Pharmacol; 2006 Nov; 46(11):1259-67. PubMed ID: 17050791
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
[TBL] [Abstract][Full Text] [Related]
6. Extended-interval Dosing of Gentamicin in Premature Neonates Born at <32 Weeks' Gestation and >7 Days of age.
Sundaram A; Alshaikh B; Dersch-Mills D; Dobry J; Akierman AR; Yusuf K
Clin Ther; 2017 Jun; 39(6):1233-1241. PubMed ID: 28579209
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic outcomes of a simplified, weight-based, extended-interval gentamicin dosing protocol in critically ill neonates.
Hoff DS; Wilcox RA; Tollefson LM; Lipnik PG; Commers AR; Liu M
Pharmacotherapy; 2009 Nov; 29(11):1297-305. PubMed ID: 19857147
[TBL] [Abstract][Full Text] [Related]
8. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
9. Otoacoustic emission screen results in critically ill neonates who received gentamicin in the first week of life.
Cooper AC; Commers AR; Finkelstein M; Lipnik PG; Tollefson LM; Wilcox RA; Hoff DS
Pharmacotherapy; 2011 Jul; 31(7):649-57. PubMed ID: 21923451
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
Staatz CE; Byrne C; Thomson AH
Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing.
Xuan D; Nicolau DP; Nightingale CH
Int J Antimicrob Agents; 2004 Mar; 23(3):291-5. PubMed ID: 15164971
[TBL] [Abstract][Full Text] [Related]
12. Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients.
Zakova M; Pong S; Trope A; Atenafu EG; Papaioannou V; Bitnun SA; Richardson S; Schwartz S; Cox P; Parshuram C; Seto W
Ther Drug Monit; 2014 Jun; 36(3):288-94. PubMed ID: 24695354
[TBL] [Abstract][Full Text] [Related]
13. A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.
Sweileh WM
Fundam Clin Pharmacol; 2009 Aug; 23(4):515-20. PubMed ID: 19709328
[TBL] [Abstract][Full Text] [Related]
14. Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study.
van Maarseveen EM; Sprij A; Touw DJ
Ther Drug Monit; 2016 Jun; 38(3):402-6. PubMed ID: 26836810
[TBL] [Abstract][Full Text] [Related]
15. Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis.
Hodiamont CJ; Juffermans NP; Bouman CS; de Jong MD; Mathôt RA; van Hest RM
Int J Antimicrob Agents; 2017 Feb; 49(2):204-211. PubMed ID: 28038961
[TBL] [Abstract][Full Text] [Related]
16. Validation of a dosage individualization table for extended-interval gentamicin in neonates.
Dersch-Mills D; Akierman A; Alshaikh B; Yusuf K
Ann Pharmacother; 2012; 46(7-8):935-42. PubMed ID: 22739714
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of four once-daily aminoglycoside dosing nomograms.
Wallace AW; Jones M; Bertino JS
Pharmacotherapy; 2002 Sep; 22(9):1077-83. PubMed ID: 12222541
[TBL] [Abstract][Full Text] [Related]
18. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
19. Extended interval dosing of gentamicin in premature neonates ≤ 28-week gestation.
Alshaikh B; Dersch-Mills D; Taylor R; Akierman AR; Yusuf K
Acta Paediatr; 2012 Nov; 101(11):1134-9. PubMed ID: 22897142
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition.
Seaton C; Ignas J; Muchohi S; Kokwaro G; Maitland K; Thomson AH
J Antimicrob Chemother; 2007 Apr; 59(4):681-9. PubMed ID: 17347177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
